2018
A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC).
Giuroiu I, Ku G, Leichman L, Du K, Oh P, Levinson B, Iqbal S, Thomas C, Wu J. A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC). Journal Of Clinical Oncology 2018, 36: tps199-tps199. DOI: 10.1200/jco.2018.36.4_suppl.tps199.Peer-Reviewed Original ResearchEsophageal squamous cell carcinomaAdvanced esophageal squamous cell carcinomaPathologic complete responseOverall survivalClinical CRRadiation therapyMedian progression-free survivalPhase IEfficacy of nivolumabCarboplatin/paclitaxelOverall survival benefitProgression-free survivalKaplan-Meier curvesSquamous cell carcinomaMulti-center studyLast dosePrimary endpointUnacceptable toxicitySurvival benefitComplete responseMeier curvesAbscopal effectCell carcinomaExtensive tumorsEsophageal cancer
2014
Outcomes of rectal cancer with liver oligometastases
Resende Salgado L, Hsu H, Du K. Outcomes of rectal cancer with liver oligometastases. Journal Of Gastrointestinal Oncology 2014, 5: 414-20. PMID: 25436119, PMCID: PMC4226821, DOI: 10.3978/j.issn.2078-6891.2014.078.Peer-Reviewed Original ResearchRectal cancer patientsTotal mesorectal excisionProgression-free survivalCourse chemoradiationLiver metastasesOverall survivalCancer patientsLocal controlRectal cancerDistant metastasisMean PFS timeOligometastatic colorectal cancerOligometastatic rectal cancerPelvic lymph nodesKaplan-Meier methodMulti-modality treatment approachSingle institution experienceTime of diagnosisGoals of careKaplan-Meier analysisEquivalent local controlMean survival timeLong-term survivalYears of ageCensoring deaths